These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 8538625)

  • 21. Okadaic acid: a reversible inhibitor of neoplastic transformation of mouse fibroblasts.
    Mordan LJ; Dean NM; Honkanen RE; Boynton AL
    Cancer Commun; 1990; 2(7):237-41. PubMed ID: 2165798
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chinese hamster ovary cells resistant to okadaic acid express a multidrug resistant phenotype.
    Tohda H; Yasui A; Yasumoto T; Nakayasu M; Shima H; Nagao M; Sugimura T
    Biochem Biophys Res Commun; 1994 Sep; 203(2):1210-6. PubMed ID: 7916570
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential regulation of jun family gene expression by the tumor promoter okadaic acid.
    Schönthal A; Alberts AS; Frost JA; Feramisco JR
    New Biol; 1991 Oct; 3(10):977-86. PubMed ID: 1662987
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Affinity of okadaic acid to type-1 and type-2A protein phosphatases is markedly reduced by oxidation of its 27-hydroxyl group.
    Sasaki K; Murata M; Yasumoto T; Mieskes G; Takai A
    Biochem J; 1994 Mar; 298 ( Pt 2)(Pt 2):259-62. PubMed ID: 8135728
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mechanisms of action of okadaic acid class tumor promoters on mouse skin.
    Fujiki H; Suganuma M; Yoshizawa S; Nishiwaki S; Winyar B; Sugimura T
    Environ Health Perspect; 1991 Jun; 93():211-4. PubMed ID: 1663450
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Induction of minisatellite mutation in NIH 3T3 cells by treatment with the tumor promoter okadaic acid.
    Nakagama H; Kaneko S; Shima H; Inamori H; Fukuda H; Kominami R; Sugimura T; Nagao M
    Proc Natl Acad Sci U S A; 1997 Sep; 94(20):10813-6. PubMed ID: 9380716
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Apoptosis induced by protein phosphatase 2A (PP2A) inhibition in T leukemia cells is negatively regulated by PP2A-associated p38 mitogen-activated protein kinase.
    Boudreau RT; Conrad DM; Hoskin DW
    Cell Signal; 2007 Jan; 19(1):139-51. PubMed ID: 16844342
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Okadaic acid induces DNA fragmentation via caspase-3-dependent and caspase-3-independent pathways in Chinese hamster ovary (CHO)-K1 cells.
    Kitazumi I; Maseki Y; Nomura Y; Shimanuki A; Sugita Y; Tsukahara M
    FEBS J; 2010 Jan; 277(2):404-12. PubMed ID: 19968860
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lack of DNA damage induction by okadaic acid, a marine toxin, in the CHO-Hprt and the in vitro UDS assays.
    Le Hégarat L; Nesslany F; Mourot A; Marzin D; Fessard V
    Mutat Res; 2004 Dec; 564(2):139-47. PubMed ID: 15507378
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Protein serine/threonine phosphatases and cell transformation.
    Walter G; Mumby M
    Biochim Biophys Acta; 1993 Aug; 1155(2):207-26. PubMed ID: 8395218
    [No Abstract]   [Full Text] [Related]  

  • 31. v-Src-induced transformation is inhibited by okadaic acid.
    Gupta RW; Joseph CK; Foster DA
    Biochem Biophys Res Commun; 1993 Oct; 196(1):320-7. PubMed ID: 8216307
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Structure-Activity Relationship Studies Using Natural and Synthetic Okadaic Acid/Dinophysistoxin Toxins.
    Twiner MJ; Doucette GJ; Pang Y; Fang C; Forsyth CJ; Miles CO
    Mar Drugs; 2016 Nov; 14(11):. PubMed ID: 27827901
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Unstable expression of the multi-drug-resistant phenotype in Chinese hamster ovary cells resistant to okadaic acid.
    Tohda H; Takao M; Kikuchi A; Yasumoto T; Yasui A
    Biochem Biophys Res Commun; 1997 Mar; 232(2):398-402. PubMed ID: 9125189
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of serine-threonine protein phosphatases decreases barrier function of rat pulmonary microvascular endothelial cells.
    Diwan AH; Honkanen RE; Schaeffer RC; Strada SJ; Thompson WJ
    J Cell Physiol; 1997 Jun; 171(3):259-70. PubMed ID: 9180895
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tumor necrosis factor-alpha, a new tumor promoter, engendered by biochemical studies of okadaic acid.
    Fujiki H; Suganuma M
    J Biochem; 1994 Jan; 115(1):1-5. PubMed ID: 8188614
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibitory effect of okadaic acid derivatives on protein phosphatases. A study on structure-affinity relationship.
    Takai A; Murata M; Torigoe K; Isobe M; Mieskes G; Yasumoto T
    Biochem J; 1992 Jun; 284 ( Pt 2)(Pt 2):539-44. PubMed ID: 1318034
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Abbreviated cell cycle progression induced by the serine/threonine protein phosphatase inhibitor okadaic acid at concentrations that promote neoplastic transformation.
    Messner DJ; Ao P; Jagdale AB; Boynton AL
    Carcinogenesis; 2001 Aug; 22(8):1163-72. PubMed ID: 11470744
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Okadaic acid: chromosomal non-disjunction analysis in human lymphocytes and study of aneugenic pathway in CHO-K1 cells.
    Hégarat LL; Orsière T; Botta A; Fessard V
    Mutat Res; 2005 Oct; 578(1-2):53-63. PubMed ID: 15885711
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ability of okadaic acid and other protein phosphatase inhibitors to mimic the stimulatory effects of 12-O-tetradecanoylphorbol-13-acetate on hydroperoxide production in mouse epidermis in vivo.
    Newell SW; Perchellet EM; Gao XM; Chen G; Perchellet JP
    Cancer Lett; 1996 Jan; 98(2):241-51. PubMed ID: 8556715
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Establishment of a human small-cell lung-cancer subline resistant to okadaic acid.
    Takeda Y; Nishio K; Kubota N; Miura K; Morikage T; Ohmori T; Kudoh S; Niitani H; Saijo N
    Int J Cancer; 1994 Sep; 58(6):882-90. PubMed ID: 7927883
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.